Dirk Thye, CEO and Chief Medical Officer: Quince Therapeutics QNCX Buy · Filed 24/09/03

Trade details

Type: Insider buy
Amount: $53,475
Shares · price: 77,500 sh · $0.69 a share
Held after: 766,941 sh
Stock: Quince Therapeutics QNCX
Person: Dirk ThyeCEO and Chief Medical Officer
Trade date: 24/08/29
Filed: 24/09/03
Days to filing: 5 days

First buy in 1 years

Since the last buy: 1.1 years
Last buy: 23/08/10
Insiders buying this week: 1 insiders
Holding change: +11.2%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/30~24/09/28

Dirk Thye's recent trades

Dirk ThyeCEO and Chief Medical Officer
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$53.9K
77,000 sh
$53.9K
Filed 24/09/03
Traded 24/08/30
Dirk ThyeCEO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$110.9K
88,000 sh
$110.9K
Filed 23/08/11
Traded 23/08/10
Dirk ThyeCEO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$99.2K
80,000 sh
$99.2K
Filed 23/08/09
Traded 23/08/08

Dirk Thye, CEO — bought $53.5K of Quince Therapeutics QNCX · 77,500 sh @ $0.69 | Whalegun